| Anticoagulation after artificial valve replacement with or without atrial fibrillation: how much is really needed? | |
| | |
MedLine Citation:
|
PMID: 10695504 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Insertion of a mechanical artificial heart valve is an absolute indication for the use of lifelong oral anticoagulation, irrespective the presence or absence of atrial fibrillation. Depending on the type and position of the artificial valve the optimal International Normalized Ratio (INR) for these patients is between 2.5 and 4.5, although more prospective studies on the optimal range of oral anticoagulation are necessary. Addition of low dose antiplatelet therapy may further decrease the rate of thromboembolism, but also here more studies are needed. Patients with a bioprosthesis need only oral anticoagulation for the first three months following surgery in the absence of an indication for anticoagulation for other conditions. Atrial fibrillation is often seen in patients with artificial heart valves. Stroke prevention can be instituted by the mandatory oral anticoagulant therapy. The presence of atrial fibrillation and the use of oral anticoagulation prior to heart valve surgery support the indication for the insertion of a mechanical artificial heart valve. However, relative contraindications to oral anticoagulation and the presence of sinus rhythm may favor the use of a bioprosthesis. |
| | |
Authors:
|
F W Verheugt |
Related Documents
:
|
18296394 - Apical rotating flow and right ventricular cerebral compression. 15132664 - Anticoagulant and antiplatelet agents: their clinical and device application(s) togethe... 8239824 - Clinical cardiopulmonary bypass without systemic anticoagulation. 16480434 - A hundred years of cascading - started by paul morawitz (1879-1936), a pioneer of haemo... 1703244 - The relationship between 24 hour total heart beats or ventricular arrhythmias and cardi... 1125114 - Accuracy of echocardiography for assessing aortic root diameter. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Thrombosis and haemostasis Volume: 82 Suppl 1 ISSN: 0340-6245 ISO Abbreviation: Thromb. Haemost. Publication Date: 1999 Sep |
Date Detail:
|
Created Date: 2000-03-22 Completed Date: 2000-03-22 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 7608063 Medline TA: Thromb Haemost Country: GERMANY |
Other Details:
|
Languages: eng Pagination: 130-5 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Heartcenter, University Hospital Nijmegen, The Netherlands. f.verheugt@cardio.azn.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticoagulants
/
administration & dosage,
therapeutic use* Atrial Fibrillation / etiology Heart Valve Prosthesis Heart Valve Prosthesis Implantation* / adverse effects Heart Valves / surgery* Humans Thrombosis / etiology, prevention & control* |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism.
Next Document: Platelet glycoprotein IIb/IIIa receptor blockade: lessening the risk of coronary interventions.